Key Takeaways
Does ADHD Get Worse With Age? What the Evidence Says
Does ADHD get worse with age? For most people, no. Long-term follow-up studies show that symptoms of ADHD tend to lessen from childhood into adulthood, though most people diagnosed as children still carry some impairing symptoms years later[2].
A 2006 meta-analysis of controlled follow-up studies found that only about 15% of children with ADHD still met full diagnostic criteria at age 25[2]. When people in partial remission were counted, persistence rose to about 65%[2].
The authors concluded that, under either definition, evidence for ADHD lessens with age[2]. They could not say whether this reflects true remission or diagnostic criteria that fit children better than adults[2].
So the answer has three parts. Symptoms usually ease, few people lose them entirely, and the course often rises and falls rather than following a straight line[3]. Some life stages, including perimenopause, are associated with heavier symptom loads[7].
ADHD in partial remission
A label for someone who once met full diagnostic criteria for ADHD and now has fewer symptoms than the full threshold, but whose remaining symptoms still cause impairment. Studies that count partial remission as persistence report far higher persistence rates than studies that count only full-criteria cases[2].
Related Terms
Source: Faraone, Biederman and Mick, Psychological Medicine (2006)
Which ADHD Symptoms Fade and Which Persist With Age
The clearest age pattern is in the kind of symptom. According to the National Institute of Mental Health, inattentive symptoms often persist as people get older, while hyperactivity and impulsivity are more likely to decline[1].
In adults, hyperactivity tends to show up as restlessness and a need for constant activity[1]. Inattention shows up as disorganization, procrastination, poor time management and trouble finishing large projects[1].
The diagnostic bar also changes with age. Adolescents over 16 and adults need five symptoms of inattention or hyperactivity-impulsivity rather than six[1].
Because the mix of symptoms shifts, a person's presentation can change over time, for example from combined to mainly inattentive. That pattern is covered in types of ADHD, and how symptoms look at work and at home is covered in signs of ADHD in adults.
What Long-Term Studies Found About ADHD and Age
| Study | Population | Key finding |
|---|---|---|
| Follow-up meta-analysis (2006) | Controlled follow-up studies of childhood ADHD | ~15% met full criteria at 25; ~65% counting partial remission |
| MTA study (2022) | 558 children followed to mean age 25 | 9.1% sustained recovery; 63.8% fluctuated; 10.8% stable persistence |
| E-Risk twin cohort (2016) | 2,040 twins in England and Wales | 21.9% of childhood cases still met criteria at 18 |
| Perimenopause cohort (2025) | 535 women with ADHD, 4,857 without | Severe perimenopausal symptoms: 54.2% vs. 30.1% |
| Older-adult meta-analysis (2020) | Older adults, pooled studies | 2.18% by symptom scales; 0.23% by clinical diagnosis |
| LASA, Netherlands (2012) | 1,494 older adults screened | 2.8% full (syndromatic) ADHD; 4.2% symptomatic |
Selected longitudinal and population studies on how ADHD changes with age; each study defines persistence differently[2][3][5][7][8][9].
1Syndromatic ADHD means full diagnostic criteria are met; symptomatic ADHD means elevated symptoms below or around the full threshold.
2Figures are not directly comparable across rows because samples, ages and definitions differ.
Sources
- •Faraone et al., Psychological Medicine, 2006
- •Sibley et al., American Journal of Psychiatry, 2022
- •Agnew-Blais et al., JAMA Psychiatry, 2016
- •Smári et al., European Psychiatry, 2025
- •Dobrosavljevic et al., Neuroscience & Biobehavioral Reviews, 2020
- •Michielsen et al., British Journal of Psychiatry, 2012
Remission Is Often Temporary: What the MTA Study Found
Single snapshots can make ADHD look like it simply fades. The Multimodal Treatment Study of ADHD (MTA) assessed 558 children eight times, from about age 10 to a mean age of 25, and found a more uneven picture[3].
About 30% of the children reached full remission at some point, but 60% of those saw ADHD return after that remission[3]. Only 9.1% showed sustained recovery by the end of the study, and 10.8% had stable, uninterrupted ADHD[3].
The largest group, 63.8%, moved between periods of remission and recurrence[3]. The authors concluded that 90% of the children continued to have residual symptoms into young adulthood[3].
A 2024 follow-up analysis of the same cohort found that remission periods usually first appeared in adolescence[4]. Remission was associated with higher, not lower, environmental demands, and that link weakened as participants moved through adulthood[4].
Symptoms that return after a quieter stretch fit the pattern the MTA observed, which differs from a steady decline.
Children with ADHD in the MTA study whose symptoms moved between remission and recurrence over 16 years
Only 9.1% showed sustained recovery and 10.8% showed stable persistence. For most people, ADHD neither steadily worsens nor disappears; it fluctuates.
"Most participants with ADHD (63.8%) had fluctuating periods of remission and recurrence over time."
Why ADHD Can Feel Worse in Adulthood
Symptoms that stay the same can still cause more trouble when circumstances change. NIMH notes that some people have a milder form of ADHD that was managed well until they faced the stresses and demands of adulthood, especially at work[1].
That is one reason adult diagnosis is common. In 2023, an estimated 15.5 million U.S. adults (6.0%) reported a current ADHD diagnosis, and about half received it at age 18 or older[6]. Detailed adult figures are on the adults with ADHD page.
Some adults appear to meet criteria for the first time after childhood. In a British twin cohort, 112 of 166 young adults with ADHD at 18 (67.5%) had not met criteria at any childhood assessment[5]. Whether this represents true late onset or symptoms missed earlier is still debated.
Other conditions can make ADHD feel worse. Sleep problems affect up to 70% of adults with ADHD, and ADHD often co-occurs with other mental disorders that can make both harder to treat[1]. Overlaps are covered in ADHD and anxiety and ADHD and depression.
Persistent ADHD is associated with more impairment than remitted ADHD. At 18, twins whose childhood ADHD persisted had 5.19 times the odds of generalized anxiety disorder compared with those whose ADHD had remitted[5].
ADHD, Perimenopause and Menopause
Midlife is one period when symptoms can genuinely intensify for women. A 2025 population-based cohort compared 535 women with ADHD and 4,857 without it on the Menopause Rating Scale[7].
Women with ADHD had higher total perimenopausal symptom scores (18.0 vs. 13.0), and 54.2% reported severe symptoms compared with 30.1% of women without ADHD[7]. Severe psychological symptoms were reported by 58.6% vs. 36.0%[7].
The gap was largest at ages 35 to 39 (19.0 vs. 12.5), which the authors read as a sign that perimenopause may begin earlier in women with ADHD[7]. ADHD diagnosis in the study was self-reported, and the design shows association, not cause[7].
Late diagnosis, pregnancy and menopause in women are covered in more depth in ADHD in adult women.
What Happens to ADHD in Older Adults
ADHD does not disappear in later life, but it is rarely diagnosed. A 2020 meta-analysis found a pooled prevalence of 2.18% in older adults when validated symptom scales were used, compared with 0.23% based on clinical diagnoses and 0.09% based on treatment rates[8].
The Longitudinal Aging Study Amsterdam estimated 2.8% of older adults had full (syndromatic) ADHD and 4.2% had symptomatic ADHD[9]. Adults aged 60 to 70 reported significantly more ADHD symptoms than those aged 71 to 94[9].
That age gradient is consistent with symptoms continuing to ease late in life, though a single survey cannot separate aging from generational differences. Figures for this age group are on the adults 65 and older population page.
Is It ADHD or Dementia? What Cohort Studies Show
Forgetfulness and distractibility in later life raise an obvious question: is this ADHD, normal aging or early dementia? Cohort studies suggest the conditions are linked, though they cannot show that one causes the other.
An Israeli cohort followed 109,218 adults aged 51 to 70 for 17.2 years[10]. Dementia was diagnosed in 13.2% of those with adult ADHD and 7.0% of those without, an adjusted hazard ratio of 2.77[10].
In the same study, there was no clear increase in dementia risk among people with ADHD who received psychostimulant medication[10]. Only 22.3% of participants with ADHD received such treatment, so this finding is limited[10].
A Swedish register study of 3,591,689 adults born from 1932 to 1963 found hazard ratios of 2.92 for dementia and 6.21 for mild cognitive impairment[11]. Adjusting for depression, anxiety, substance use disorder and bipolar disorder reduced them to 1.62 and 2.54[11].
The Swedish association was stronger in men[11]. The authors described ADHD as a potential risk factor and called for further research into the mechanisms[11].
One diagnostic rule separates ADHD from a decline that starts in later life: an ADHD diagnosis requires symptoms that began before age 12[1]. Treatment options for adults are summarized in ADHD treatment for adults.
Frequently Asked Questions
Sources & References
- National Institute of Mental Health. ADHD in Adults: 4 Things to Know. National Institutes of Health. Published 2024. Accessed October 2026. https://www.nimh.nih.gov/health/publications/adhd-what-you-need-to-know [Link]
- Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine. Published 2006. Accessed October 2026. https://doi.org/10.1017/S003329170500471X [Link]
- Sibley MH, Arnold LE, Swanson JM, et al. Variable patterns of remission from ADHD in the Multimodal Treatment Study of ADHD. American Journal of Psychiatry. Published 2022. Accessed October 2026. https://doi.org/10.1176/appi.ajp.2021.21010032 [Link]
- Sibley MH, Kennedy TM, Swanson JM, et al. Characteristics and predictors of fluctuating attention-deficit/hyperactivity disorder in the Multimodal Treatment of ADHD (MTA) Study. Journal of Clinical Psychiatry. Published 2024. Accessed October 2026. https://doi.org/10.4088/JCP.24m15395 [Link]
- Agnew-Blais JC, Polanczyk GV, Danese A, et al. Evaluation of the persistence, remission, and emergence of attention-deficit/hyperactivity disorder in young adulthood. JAMA Psychiatry. Published 2016. Accessed October 2026. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2522750 [Link]
- Staley BS, Robinson LR, Claussen AH, et al. Attention-deficit/hyperactivity disorder diagnosis, treatment, and telehealth use in adults: National Center for Health Statistics Rapid Surveys System, United States, October-November 2023. MMWR Morbidity and Mortality Weekly Report. Published 2024. Accessed October 2026. https://www.cdc.gov/mmwr/volumes/73/wr/mm7340a1.htm [Link]
- Smári UJ, Valdimarsdottir UA, Wynchank D, et al. Perimenopausal symptoms in women with and without ADHD: a population-based cohort study. European Psychiatry. Published 2025. Accessed October 2026. https://doi.org/10.1192/j.eurpsy.2025.10101 [Link]
- Dobrosavljevic M, Solares C, Cortese S, Andershed H, Larsson H. Prevalence of attention-deficit/hyperactivity disorder in older adults: a systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews. Published 2020. Accessed October 2026. https://doi.org/10.1016/j.neubiorev.2020.07.042 [Link]
- Michielsen M, Semeijn E, Comijs HC, et al. Prevalence of attention-deficit hyperactivity disorder in older adults in the Netherlands. British Journal of Psychiatry. Published 2012. Accessed October 2026. https://doi.org/10.1192/bjp.bp.111.101196 [Link]
- Levine SZ, Rotstein A, Kodesh A, et al. Adult attention-deficit/hyperactivity disorder and the risk of dementia. JAMA Network Open. Published 2023. Accessed October 2026. https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2810766 [Link]
- Dobrosavljevic M, Zhang L, Garcia-Argibay M, et al. Attention-deficit/hyperactivity disorder as a risk factor for dementia and mild cognitive impairment: a population-based register study. European Psychiatry. Published 2022. Accessed October 2026. https://doi.org/10.1192/j.eurpsy.2021.2261 [Link]